share_log

证监会:博安生物境外IPO申请已获接收材料

Securities Regulatory Commission: Boan Biotech's overseas IPO application has received materials

Zhitong Finance ·  Apr 22, 2022 14:07

The Zhitong Finance App learned that on April 20, the Securities Regulatory Commission announced the progress of Shandong Boan Biotechnology Co., Ltd.'s “Approval of Overseas Initial Public Offering of Shares (Including Various Types of Shares and Derivative Forms of Shares such as Common Shares and Preferred Shares)” of Shandong Boan Biotechnology Co., Ltd. The progress has now reached the stage of receiving materials.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment